A drug used with misoprostol for medical abortion; at the center of U.S. legal fights
The Supreme Court is weighing an emergency petition to pause a Fifth Circuit ruling that would restrict mifepristone access, while allowing telemedicine and mail delivery to continue for now. The government and manufacturers urge a rapid decision, as lower-court moves threaten broad abortion access.
The Supreme Court has issued an emergency order keeping mifepristone available by mail and via telehealth while litigation continues. The action preserves access as lawsuits challenge FDA rules on prescribing the abortion pill, with a ruling likely not until next year.